It is a pharma private limited company based in Patna, Bihar, India, established in 2016.
2016 | Patna, Bihar, India | ActiveOncomed Pharmaceuticals India Private Limited, a active private limited company, was established on 18 August 2016 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290BR2016PTC032302. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Smita Khosla (Director), Deepak Kumar (Director). It holds ₹2.01 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 503 Three Palm Vihar Apartment Khajpura B V College Ashiana, Patna, Bihar, 800014.
U24290BR2016PTC032302
032302
18 August 2016
₹0.50 M
₹0.40 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Oncomed Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Smita Khosla | Director | 18 Aug 2016 | Current |
| Deepak Kumar | Director | 18 Aug 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oncomed Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 926.16% increase. The company also saw a substantial improvement in profitability, with a 841.33% increase in profit. The company's net worth Soared by an impressive increase of 93.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Oncomed Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,010,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Aug 2025 | Hdfc Bank Limited | ₹2.01 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Oncomed Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oncomed Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncomed Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Oncomed Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.01 M with Charge ID 101149661 was registered on 20 Aug 2025. was documented.
The activity Oncomed Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna. was completed.
The activity Smita Khosla was appointed as a Director was appointed as a Director on 18 Aug 2016 & has been associated with this company since 9 years 4 months . was completed.
Progress on Deepak Kumar was appointed as a Director was appointed as a Director on 18 Aug 2016 & has been associated with this company since 9 years 4 months . was documented.
The activity Oncomed Pharmaceuticals India Private Limited was registered on 18 Aug 2016 with Roc Patna & aged 9 years 4 months as per MCA records. was completed.
The CIN of Oncomed Pharmaceuticals India Private Limited is U24290BR2016PTC032302.
Oncomed Pharmaceuticals India Private Limited is headquartered at 503 Three Palm Vihar Apartment Khajpura B V College Ashiana, Patna, Bihar, 800014.
Oncomed Pharmaceuticals India Private Limited was incorporated on 18 August 2016.
The current directors of Oncomed Pharmaceuticals India Private Limited are
The primary industry of Oncomed Pharmaceuticals India Private Limited is Trade.
Oncomed Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Oncomed Pharmaceuticals India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.40 M.
The compliance status of Oncomed Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX